cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.13145/bacdive10685.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10686.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10687.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10688.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10689.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10690.20191129.4.1
title: Dermatophilus congolensis (van Saceghem 1915) Gordon 1964 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.5281/zenodo.4437868
title: Transcript quantification data from Varabyou et al. 2020 simulations

description: Transcript quantification data from different methods and configurations and simulated counts for simulated samples. The quantification results are in quants.tar.gz, and the true transcript fragment counts are in true_counts.tar.gz.
description: {"references": ["Varabyou, Ales, Steven Lloyd Salzberg, and Mihaela Pertea. \"Effects of transcriptional noise on estimates of gene and transcript expression in RNA sequencing experiments.\" Genome Research (2020): gr-266213."]}
DOI: 10.13145/bacdive10691.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.5281/zenodo.4437867
title: Transcript quantification data from Varabyou et al. 2020 simulations

description: Transcript quantification data from different methods and configurations and simulated counts for simulated samples. The quantification results are in quants.tar.gz, and the true transcript fragment counts are in true_counts.tar.gz.
description: {"references": ["Varabyou, Ales, Steven Lloyd Salzberg, and Mihaela Pertea. \"Effects of transcriptional noise on estimates of gene and transcript expression in RNA sequencing experiments.\" Genome Research (2020): gr-266213."]}
DOI: 10.13145/bacdive10692.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10693.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10694.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10695.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10696.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10697.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10698.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10699.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10700.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10701.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10702.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10703.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10704.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10705.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10706.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10707.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10708.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10709.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10710.20191129.4.1
title: Nocardia sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10711.20191129.4.1
title: Nocardia amikacinitolerans Ezeoke et al. 2013 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10712.20191129.4.1
title: Nocardia amikacinitolerans Ezeoke et al. 2013 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10713.20191129.4.1
title: Nocardia amikacinitolerans Ezeoke et al. 2013 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10714.20191129.4.1
title: Nocardia amikacinitolerans Ezeoke et al. 2013 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10715.20191129.4.1
title: Nocardia amikacinitolerans Ezeoke et al. 2013 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10716.20191129.4.1
title: Streptomyces sp.

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10717.20191129.4.1
title: Nocardia transvalensis Pijper and Pullinger 1927 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10718.20191129.4.1
title: Nocardia transvalensis Pijper and Pullinger 1927 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10719.20191129.4.1
title: Nocardia uniformis (ex Marton and Szabó 1959) Isik et al. 1999 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10720.20191129.4.1
title: Nocardia uniformis (ex Marton and Szabó 1959) Isik et al. 1999 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10721.20191129.4.1
title: Nocardia vaccinii Demaree and Smith 1952 emend. Nouioui et al. 2018

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10722.20191129.4.1
title: Nocardia mexicana Rodríguez-Nava et al. 2006

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.13145/bacdive10724.20191129.4.1
title: Nocardia globerula (Gray 1928) Waksman and Henrici 1948

description: The range of data encompasses taxonomy, morphology, physiology, sampling and concomitant environmental conditions as well as molecular biology.
DOI: 10.15468/dl.8k5va8
title: Occurrence Download

description: A dataset containing 480 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ziziphus jujuba var. inermis (Bunge) Rehder",
 "Country is China",
 "Year is greater than or equal to 1900",
 "HasCoordinate is true"
 ]
}

 The dataset includes 480 records from 10 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081636-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.pbq4gt
title: Occurrence Download

description: A dataset containing 13 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Pseudocorchorus alatus Capuron"
 ]
}

 The dataset includes 13 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081637-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.esb3un
title: Occurrence Download

description: A dataset containing 35812 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is one of (Observation, Machine Observation, Human Observation, Material sample, Material citation, Specimen, Living Specimen, Occurrence evidence)",
 "Continent is Europe",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Rhododendron tomentosum (Stokes) Harmaja",
 "Year 2000-2024"
 ]
}

 The dataset includes 35812 records from 99 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081635-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.jbzyzc
title: Occurrence Download

description: A dataset containing 982 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Euonymus maackii Rupr.",
 "Country is China",
 "Year is greater than or equal to 1900",
 "HasCoordinate is true"
 ]
}

 The dataset includes 982 records from 13 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081638-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.asxv26
title: Occurrence Download

description: A dataset containing 3 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Prunus aitchisonii (Korsh.) Kitam."
 ]
}

 The dataset includes 3 records from 3 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081639-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.48597/29cn-7b4y
title: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus

description: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus
DOI: 10.48597/xb2c-fmyv
title: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus

description: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus
DOI: 10.48597/xfz6-d3kj
title: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus

description: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus
DOI: 10.48597/zh5e-shtp
title: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus

description: Measurement of Particle_number_size_distribution at Zugspitze-Schneefernerhaus
DOI: 10.6084/m9.figshare.25287786
title: Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan

description: The objectives of this study were to retrospectively investigate the patient characteristics, treatment patterns, healthcare resource utilization (HCRU), and healthcare costs related to management of neurofibromatosis type 1 (NF1) in Japan. Cohorts of NF1 patients with or without plexiform neurofibromas (PN) were identified from the Medical Data Vision database in 2008–2019. Baseline characteristics, NF1 medications, HCRU, and associated costs were assessed using descriptive statistics. All-cause HCRU and costs following the first confirmed NF1 diagnosis date were analyzed per patient per year (PPPY) in Japanese Yen (JPY) and United States Dollar (USD). A total of 4394 NF1 patients without PN and 370 NF1 patients with PN were identified. The mean age was 35.0 and 36.9 years, respectively. The proportion of patients with PN treated with medications was higher than that in patients without PN (except for antirheumatic/immunologic agents). Analgesics/non-steroidal anti-inflammatory drugs were the most frequently prescribed NF1 medications (44.3% and 56.0% in patients without and with PN, respectively), followed by inpatient prescriptions of opioids/opioid-like agents (17.8% and 27.6%, respectively). Inpatient admissions accounted for the highest costs in both cohorts with the average cost PPPY being JPY 2,133,277 (USD 19,861) for patients without PN and JPY 1,052,868 (USD 9802) for patients with PN. NF1 is treated primarily with supportive care with analgesics/non-steroidal anti-inflammatory drugs being the most frequently prescribed NF1 medications in Japan. Findings underscored the unmet need and substantial economic burden among patients with NF1 and highlighted the need for new treatment options for patients with this disease.
DOI: 10.6084/m9.figshare.25287786.v2
title: Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan

description: The objectives of this study were to retrospectively investigate the patient characteristics, treatment patterns, healthcare resource utilization (HCRU), and healthcare costs related to management of neurofibromatosis type 1 (NF1) in Japan. Cohorts of NF1 patients with or without plexiform neurofibromas (PN) were identified from the Medical Data Vision database in 2008–2019. Baseline characteristics, NF1 medications, HCRU, and associated costs were assessed using descriptive statistics. All-cause HCRU and costs following the first confirmed NF1 diagnosis date were analyzed per patient per year (PPPY) in Japanese Yen (JPY) and United States Dollar (USD). A total of 4394 NF1 patients without PN and 370 NF1 patients with PN were identified. The mean age was 35.0 and 36.9 years, respectively. The proportion of patients with PN treated with medications was higher than that in patients without PN (except for antirheumatic/immunologic agents). Analgesics/non-steroidal anti-inflammatory drugs were the most frequently prescribed NF1 medications (44.3% and 56.0% in patients without and with PN, respectively), followed by inpatient prescriptions of opioids/opioid-like agents (17.8% and 27.6%, respectively). Inpatient admissions accounted for the highest costs in both cohorts with the average cost PPPY being JPY 2,133,277 (USD 19,861) for patients without PN and JPY 1,052,868 (USD 9802) for patients with PN. NF1 is treated primarily with supportive care with analgesics/non-steroidal anti-inflammatory drugs being the most frequently prescribed NF1 medications in Japan. Findings underscored the unmet need and substantial economic burden among patients with NF1 and highlighted the need for new treatment options for patients with this disease.
DOI: 10.15468/dl.v9vxwz
title: Occurrence Download

description: A dataset containing 116 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Psychotria holtzii (K.Schum.) E.M.A.Petit"
 ]
}

 The dataset includes 116 records from 11 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081640-240321170329656/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.25287786.v1
title: Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan

description: Objectives: The objectives of this study were to retrospectively investigate the patient characteristics, treatment patterns, healthcare resource utilization (HCRU), and healthcare costs related to management of neurofibromatosis type 1 (NF1) in Japan. Methods: Cohorts of NF1 patients with or without plexiform neurofibromas (PN) were identified from the Medical Data Vision database in 2008-2019. Baseline characteristics, NF1 medications, HCRU, and associated costs were assessed using descriptive statistics. All-cause HCRU and costs following the first confirmed NF1 diagnosis date were analyzed per patient per year (PPPY) in Japanese Yen (JPY) and United States Dollar (USD). Results: A total of 4,394 NF1 patients without PN and 370 NF1 patients with PN were identified. The mean age was 35.0 and 36.9 years, respectively. The proportion of patients with PN treated with medications was higher than that in patients without PN (except for antirheumatic/immunologic agents). Analgesics/non-steroidal anti-inflammatory drugs were the most frequently prescribed NF1 medications (44.3% and 56.0% in patients without and with PN, respectively), followed by inpatient prescriptions of opioids/opioid-like agents (17.8% and 27.6%, respectively). Inpatient admissions accounted for the highest costs in both cohorts with the average cost PPPY being JPY 2,133,277 (USD 19,861) for patients without PN and JPY 1,052,868 (USD 9,802) for patients with PN. Conclusions: NF1 is treated primarily with supportive care with analgesics/non-steroidal anti-inflammatory drugs being the most frequently prescribed NF1 medications in Japan. Findings underscored the unmet need and substantial economic burden among patients with NF1 and highlighted the need for new treatment options for patients with this disease.
DOI: 10.6084/m9.figshare.25243158
title: Association of echocardiography-related parameters with the prognosis of decompensated cirrhosis: a retrospective cohort study

description: Cardiac morphology and function, which are conventionally evaluated by echocardiography, are often abnormal in decompensated cirrhosis. We aimed to evaluate the association of echocardiography-related parameters with prognosis in cirrhosis. This retrospective study included 104 decompensated cirrhotic patients, in whom cardiac structure and function were measured by echocardiography, including mitral inflow early diastolic velocity/mitral inflow late diastolic velocity (E/A), left atrium diameter, left ventricular end-diastolic dimension, interventricular septal thickness, left ventricular posterior wall thickness, right atrial transverse diameter, right atrial longitudinal diameter, right ventricular dimension (RVD), stroke volume, cardiac output, left ventricular ejection fraction, and fractional shortening. Cox regression and competing risk analyses and Kaplan-Meier and Nelson-Aalen cumulative risk curves were used to evaluate their associations with further decompensation and death in cirrhotic patients, if appropriate. Lower RVD was a predictor of further decompensation in Cox regression (adjusted by Child-Pugh score: <i>p</i> = 0.138; adjusted by MELD score: <i>p</i> = 0.034) and competing risk analyses (<i>p</i> = 0.003), and RVD ≤17 mm was significantly associated with higher cumulative incidence of further decompensation in Kaplan-Meier (<i>p</i> = 0.002) and Nelson-Aalen cumulative risk curves (<i>p</i> = 0.002). E/<i>A</i> ≤ 0.8 was a significant predictor of death in Cox regression (adjusted by Child-Pugh score: <i>p</i> = 0.041; adjusted by MELD score: <i>p</i> = 0.045) and competing risk analyses (<i>p</i> = 0.024), and E/<i>A</i> ≤ 0.8 was significantly associated with higher cumulative incidence of death in Kaplan-Meier (<i>p</i> = 0.023) and Nelson-Aalen cumulative risk curves (<i>p</i> = 0.024). Other echocardiography-related parameters were not significantly associated with further decompensation or death. RVD and E/A may be considered for the prognostic assessment of decompensated cirrhosis.